Oligometastatic Prostate Cancer Clinical Trials

18 clinical trials for Oligometastatic Prostate Cancer across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. — RECRUITING · PHASE3
• Prostate Radiotherapy and Metastasis-Directed Therapy in Synchronous Oligometastatic Prostate Cancer — RECRUITING
• HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS) — RECRUITING · NA
• 5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT) — RECRUITING · NA
• Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC — RECRUITING · PHASE1
• Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer — RECRUITING · NA
• Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy — RECRUITING · PHASE2
• Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer — RECRUITING · PHASE2
• Maximal Tumor Eradication for Oligometastatic Prostate Cancer — RECRUITING · PHASE2
• Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO) — RECRUITING · PHASE2
• Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM) — WITHDRAWN
• An International, Prospective, Open-label, Multi-center, Randomized Phase III Study comparing lutetium (177Lu) vipivotide tetraxetan (AAA617) versus Observation to delay castration or disease recurrence in adult male patients with prostate-specific membrane antigen (PSMA) positive Oligometastatic Prostate Cancer (OMPC) — TERMINATED · PHASE3
• Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer — NOT_YET_RECRUITING · PHASE2
• The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer — COMPLETED · PHASE2
• Prostate Oligometastatic Cancer Management Driven by Disease Biology et/or Immunoactivity (PROMETEO) — OTHER
• Radioablation With or Without Androgen DeprIvation Therapy in Metachronous Prostate Cancer OligometaStAsis — OTHER · PHASE2
• Radiotherapy for Oligometastatic Prostate Cancer — COMPLETED · NA
• Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer — COMPLETED · NA

Refine this search